Skip to main content

Clinical Applications of the Latest Molecular Diagnostics in Noninvasive Prenatal Diagnosis

  • Chapter
  • First Online:
Book cover Chemical Diagnostics

Part of the book series: Topics in Current Chemistry ((TOPCURRCHEM,volume 336))

Abstract

The presence of cell-free fetal DNA in the plasma of pregnant women has opened up the possibility of noninvasive prenatal diagnosis. With the advances in molecular techniques of microfluidics and massive parallel sequencing, an increasing number of fetal genetic diseases/conditions can be noninvasively detected using maternal plasma DNA analysis. Remarkably, it has recently been shown that the genome-wide genetic map of an unborn fetus can be constructed through extensive sequencing of maternal plasma DNA. In this chapter the different qualitative and quantitative approaches and related methodology for the analysis of fetal DNA in maternal plasma are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lo YMD, Corbetta N, Chamberlain PF et al (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350:485–487

    Article  CAS  Google Scholar 

  2. Birch L, English CA, O'Donoghue K et al (2005) Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 51:312–320

    Article  CAS  Google Scholar 

  3. Scheffer PG, van der Schoot CE, Page-Christiaens GC et al (2010) Reliability of fetal sex determination using maternal plasma. Obstet Gynecol 115:117–126

    Article  CAS  Google Scholar 

  4. Wright CF, Burton H (2009) The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update 15:139–151

    Article  CAS  Google Scholar 

  5. Rijnders RJ, van der Schoot CE, Bossers B et al (2001) Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol 98:374–378

    Article  CAS  Google Scholar 

  6. Lo YMD, Hjelm NM, Fidler C et al (1998) Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339:1734–1738

    Article  CAS  Google Scholar 

  7. Finning K, Martin P, Summers J et al (2008) Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 336:816–818

    Article  Google Scholar 

  8. Muller SP, Bartels I, Stein W et al (2008) The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 48:2292–2301

    Article  Google Scholar 

  9. Scheffer PG, van der Schoot CE, Page-Christiaens GC et al (2011) Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. Int J Obstet Gynaecol 118:1340–1348

    Article  CAS  Google Scholar 

  10. Van der Schoot CE, Soussan AA, Koelewijn J et al (2006) Non-invasive antenatal RHD typing. Transfus Clin Biol 13:53–57

    Article  Google Scholar 

  11. Daniels G, Finning K, Martin P et al (2009) Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn 29:101–107

    Article  CAS  Google Scholar 

  12. Finning K, Martin P, Daniels G (2004) A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 1022:119–123

    Article  CAS  Google Scholar 

  13. Amicucci P, Gennarelli M, Novelli G et al (2000) Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 46:301–302

    CAS  Google Scholar 

  14. Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M et al (2003) Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR. Prenat Diagn 23:232–234

    Article  CAS  Google Scholar 

  15. Saito H, Sekizawa A, Morimoto T et al (2000) Prenatal DNA diagnosis of a single-gene disorder from maternal plasma [letter] [in process citation]. Lancet 356:1170

    Article  CAS  Google Scholar 

  16. Brojer E, Zupanska B, Guz K et al (2005) Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. Transfusion 45:1473–1480

    Article  CAS  Google Scholar 

  17. Zhou L, Thorson JA, Nugent C et al (2005) Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women. Am J Obstet Gynecol 193:1966–1971

    Article  CAS  Google Scholar 

  18. Chim SSC, Tong YK, Chiu RWK et al (2005) Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 102:14753–14758

    Article  CAS  Google Scholar 

  19. Lui YY, Chik KW, Chiu RWK et al (2002) Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 48:421–427

    CAS  Google Scholar 

  20. Chan KCA, Ding C, Gerovassili A et al (2006) Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52:2211–2218

    Article  CAS  Google Scholar 

  21. Li Y, Kazzaz JA, Kellner LH et al (2010) Incorporation of fetal DNA detection assay in a noninvasive RhD diagnostic test. Prenat Diagn 30:1010–1012

    Article  Google Scholar 

  22. Zejskova L, Jancuskova T, Kotlabova K et al (2010) Feasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma – next step toward reliable non-invasive prenatal diagnostics. Exp Mol Pathol 89:241–247

    Article  CAS  Google Scholar 

  23. Lo YMD, Tein MS, Lau TK et al (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62:768–775

    Article  CAS  Google Scholar 

  24. Lun FMF, Chiu RWK, Chan KCA et al (2008) Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 54:1664–1672

    Article  CAS  Google Scholar 

  25. Lo YMD, Zhang J, Leung TN et al (1999) Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 64:218–224

    Article  CAS  Google Scholar 

  26. Al-Yatama MK, Mustafa AS, Ali S et al (2001) Detection of Y chromosome-specific DNA in the plasma and urine of pregnant women using nested polymerase chain reaction. Prenat Diagn 21:399–402

    Article  CAS  Google Scholar 

  27. Botezatu I, Serdyuk O, Potapova G et al (2000) Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem 46:1078–1084

    CAS  Google Scholar 

  28. Illanes S, Denbow ML, Smith RP et al (2006) Detection of cell-free fetal DNA in maternal urine. Prenat Diagn 26:1216–1218

    Article  CAS  Google Scholar 

  29. Li Y, Zhong XY, Kang A et al (2003) Inability to detect cell free fetal DNA in the urine of normal pregnant women nor in those affected by preeclampsia associated HELLP syndrome. J Soc Gynecol Investig 10:503–508

    Article  CAS  Google Scholar 

  30. Illanes S, Parra M, Serra R et al (2009) Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. Prenat Diagn 29:1118–1122

    Article  CAS  Google Scholar 

  31. Lo YMD, Leung TN, Tein MS et al (1999) Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 45:184–188

    CAS  Google Scholar 

  32. Tsui DW, Chan KC, Chim SS et al (2007) Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia. Prenat Diagn 27:1212–1218

    Article  CAS  Google Scholar 

  33. Lo YMD, Lau TK, Zhang J et al (1999) Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 45:1747–1751

    CAS  Google Scholar 

  34. Zhong XY, Burk MR, Troeger C et al (2000) Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn 20:795–798

    Article  CAS  Google Scholar 

  35. Zhong XY, Laivuori H, Livingston JC et al (2001) Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 184:414–419

    Article  CAS  Google Scholar 

  36. Leung TN, Zhang J, Lau TK et al (2001) Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 47:137–139

    CAS  Google Scholar 

  37. Sifakis S, Zaravinos A, Maiz N et al (2009) First-trimester maternal plasma cell-free fetal DNA and preeclampsia. Am J Obstet Gynecol 201(472):e471–e477

    Google Scholar 

  38. Lau TW, Leung TN, Chan LYS et al (2002) Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 48:2141–2146

    CAS  Google Scholar 

  39. Gerovassili A, Garner C, Nicolaides KH et al (2007) Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities? Prenat Diagn 27:104–110

    Article  CAS  Google Scholar 

  40. Lun FMF, Tsui NBY, Chan KCA et al (2008) Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci USA 105:19920–19925

    Article  CAS  Google Scholar 

  41. Vogelstein B, Kinzler KW (1999) Digital PCR. Proc Natl Acad Sci USA 96:9236–9241

    Article  CAS  Google Scholar 

  42. Tsui NBY, Chim SSC, Chiu RWK et al (2004) Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J Med Genet 41:461–467

    Article  CAS  Google Scholar 

  43. Lo YMD, Tsui NBY, Chiu RWK et al (2007) Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 13:218–223

    Article  CAS  Google Scholar 

  44. Tsui NB, Akolekar R, Chiu RW et al (2010) Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin Chem 56:73–81

    Article  CAS  Google Scholar 

  45. Lo YMD, Lun FMF, Chan KCA et al (2007) Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 104:13116–13121

    Article  CAS  Google Scholar 

  46. Tong YK, Ding C, Chiu RWK et al (2006) Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clin Chem 52:2194–2202

    Article  CAS  Google Scholar 

  47. Tong YK, Jin S, Chiu RWK et al (2010) Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem 56:90–98

    Article  CAS  Google Scholar 

  48. Chiu RWK, Chan KCA, Gao Y et al (2008) Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 105:20458–20463

    Article  CAS  Google Scholar 

  49. Fan HC, Blumenfeld YJ, Chitkara U et al (2008) Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 105:16266–16271

    Article  CAS  Google Scholar 

  50. Chiu RWK, Akolekar R, Zheng YW et al (2011) Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 342:c7401

    Article  Google Scholar 

  51. Ehrich M, Deciu C, Zwiefelhofer T et al (2011) Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 204(205):e201–e211

    Google Scholar 

  52. Sehnert AJ, Rhees B, Comstock D et al (2011) Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 57:1042–1049

    Article  CAS  Google Scholar 

  53. Chen EZ, Chiu RW, Sun H et al (2011) Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 6:e21791

    Article  CAS  Google Scholar 

  54. Palomaki GE, Deciu C, Kloza EM et al (2012) DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 14:296–305

    Article  CAS  Google Scholar 

  55. Lun FM, Jin YY, Sun H et al (2011) Noninvasive prenatal diagnosis of a case of Down syndrome due to robertsonian translocation by massively parallel sequencing of maternal plasma DNA. Clin Chem 57:917–919

    Article  CAS  Google Scholar 

  56. Lo YMD, Chan KCA, Sun H et al (2010) Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2:61ra91

    Article  CAS  Google Scholar 

  57. Chan KCA, Zhang J, Hui AB et al (2004) Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 50:88–92

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. C. Allen Chan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Chan, K.C.A. (2012). Clinical Applications of the Latest Molecular Diagnostics in Noninvasive Prenatal Diagnosis. In: L.S. Tang, N., Poon, T. (eds) Chemical Diagnostics. Topics in Current Chemistry, vol 336. Springer, Berlin, Heidelberg. https://doi.org/10.1007/128_2012_352

Download citation

Publish with us

Policies and ethics